BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2974263)

  • 1. A comparison of oral procaterol and albuterol in reversible airflow obstruction.
    Petty TL; Brandon ML; Busse WW; Chervinsky P; Schoenweter W; Beaupre A; Boulet LP; Mazza J
    Am Rev Respir Dis; 1988 Dec; 138(6):1504-9. PubMed ID: 2974263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Mazza JA; Tashkin DP; Reed CE
    Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
    Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
    J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
    Boner AL; Sette L; Castellani C; Schiassi M
    J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of procaterol and salbutamol in single inhaled doses].
    Crespo Notario JA; Sobradillo Peña V; Garnacho López E; Ansola Zubiaurre PM; Mazo Echániz J
    Rev Clin Esp; 1989 Apr; 184(6):297-301. PubMed ID: 2526959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled procaterol versus salbutamol in bronchial asthma.
    Liippo K; Silvasti M; Tukiainen H
    Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma.
    Kemp JP; Welch MJ; Meltzer EO; Orgel HA
    Ann Allergy; 1985 Oct; 55(4):588-92. PubMed ID: 2864890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of albuterol and procaterol on exercise-induced asthma.
    Shapiro GG; Kemp JP; DeJong R; Chapko M; Bierman CW; Altman LC; Furukawa CT; Meltzer E; Orgel A; Pierson WE
    Ann Allergy; 1990 Oct; 65(4):273-6. PubMed ID: 2145791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procaterol metered-dose inhaler: a multiclinic study evaluating the efficacy and safety in patients with asthma.
    Storms WW; Chervinsky P; Bell T; Kemp JP; Brandon ML; Reed CE; Siegel SC; Repsher L
    Ann Allergy; 1989 Nov; 63(5):444-8. PubMed ID: 2573298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between oral procaterol and salbutamol in patients with bronchial asthma.
    Tukiainen H; Jaakkola J; Torkko M; Terho EO
    Curr Med Res Opin; 1988; 11(4):236-41. PubMed ID: 2975204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study between procaterol and salbutamol in mild to moderate bronchial asthma].
    Legris C; Boulet LP; Lafrance L; Bélanger J; Beaupré A
    Therapie; 1987; 42(2):213-6. PubMed ID: 2956725
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness.
    Busse WW; Sharpe G; Smith A; Arbabian M; Borgen L; Ruoho A
    Am Rev Respir Dis; 1985 Dec; 132(6):1194-8. PubMed ID: 3000233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of oral procaterol protection from methacholine-induced bronchial obstruction.
    De Candussio G; Franchi D; Manini G; Arossa W; Castello D
    Int J Clin Pharmacol Res; 1986; 6(5):403-7. PubMed ID: 2877955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
    Tinkelman DG; DeJong R; Lutz C; Spangler DL
    J Allergy Clin Immunol; 1990 Apr; 85(4):719-28. PubMed ID: 1969869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.